Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$60,999
-$20,600 QoQ
Shares Held
20,333
+51.5% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $125,736,773 across 21 Diagnostics & Research names. XGN ranks #21 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
178,851 | $22,045,174 | |
| 2 | QGEN |
Qiagen N.V.
|
493,645 | $19,765,545 | |
| 3 | A |
Agilent Technologies, Inc.
|
132,823 | $15,139,165 | |
| 4 | TWST |
Twist Bioscience Corp
|
258,604 | $12,288,862 | |
| 5 | WAT |
Waters Corp /De/
|
32,254 | $9,605,241 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
52,959 | $9,135,427 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
15,003 | $8,430,035 | |
| 8 | DHR |
Danaher Corp /De/
|
40,074 | $7,598,030 |
All Filings in XGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $60,999 | 20,333 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,599 | 13,421 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||